These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24263151)

  • 21. Successful anakinra therapy in 2 patients with Schnitzler syndrome.
    Szturz P; Adam Z; Hájek R; Mayer J
    Onkologie; 2011; 34(5):265-8. PubMed ID: 21577034
    [No Abstract]   [Full Text] [Related]  

  • 22. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.
    Calligaris L; Marchetti F; Tommasini A; Ventura A
    Eur J Pediatr; 2008 Jun; 167(6):695-6. PubMed ID: 17588171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of acute gouty arthritis in complex hospitalized patients with anakinra.
    Ghosh P; Cho M; Rawat G; Simkin PA; Gardner GC
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1381-4. PubMed ID: 23650178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol study.
    Balasubramaniam G; Parker T; Turner D; Parker M; Scales J; Harnett P; Harrison M; Ahmed K; Bhagat S; Marianayagam T; Pitzalis C; Mallen C; Roddy E; Almond M; Dasgupta B
    BMJ Open; 2017 Sep; 7(9):e017121. PubMed ID: 28877949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra.
    McGonagle D; Tan AL; Shankaranarayana S; Madden J; Emery P; McDermott MF
    Ann Rheum Dis; 2007 Dec; 66(12):1683-4. PubMed ID: 17998217
    [No Abstract]   [Full Text] [Related]  

  • 26. Erosive osteoarthritis of the hand: clinical experience with anakinra.
    Bacconnier L; Jorgensen C; Fabre S
    Ann Rheum Dis; 2009 Jun; 68(6):1078-9. PubMed ID: 19435727
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?
    Picco P; Brisca G; Traverso F; Loy A; Gattorno M; Martini A
    Arthritis Rheum; 2009 Jan; 60(1):264-8. PubMed ID: 19116906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease.
    Naumann L; Feist E; Natusch A; Langen S; Krause A; Buttgereit F; Burmester GR
    Ann Rheum Dis; 2010 Feb; 69(2):466-7. PubMed ID: 20107032
    [No Abstract]   [Full Text] [Related]  

  • 29. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anakinra treatment of SAPHO syndrome: short-term results of an open study.
    Wendling D; Prati C; Aubin F
    Ann Rheum Dis; 2012 Jun; 71(6):1098-100. PubMed ID: 22219141
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases.
    Botsios C; Sfriso P; Ostuni PA; Todesco S; Punzi L
    Rheumatology (Oxford); 2007 Jun; 46(6):1042-3. PubMed ID: 17449489
    [No Abstract]   [Full Text] [Related]  

  • 32. Expression of interleukin-1 alpha in amicrobial pustulosis of the skin folds with complete response to anakinra.
    Amazan E; Ezzedine K; Mossalayi MD; Taieb A; Boniface K; Seneschal J
    J Am Acad Dermatol; 2014 Aug; 71(2):e53-6. PubMed ID: 25037815
    [No Abstract]   [Full Text] [Related]  

  • 33. Schnitzler syndrome: response to anakinra in two cases and a review of the literature.
    Schuster C; Kränke B; Aberer E; Arbab E; Sturm G; Aberer W
    Int J Dermatol; 2009 Nov; 48(11):1190-4. PubMed ID: 20064173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature.
    Gran JT; Midtvedt Ø; Haug S; Aukrust P
    Scand J Rheumatol; 2011 Jan; 40(1):74-9. PubMed ID: 20936987
    [No Abstract]   [Full Text] [Related]  

  • 35. Utility of Anakinra in Acute Crystalline Diseases: A Retrospective Study Comparing a University Hospital with a Veterans Affairs Medical Center.
    Desmarais J; Chu CQ
    J Rheumatol; 2019 Jul; 46(7):748-750. PubMed ID: 30442822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adult-onset Still's disease in a patient with cystic fibrosis and its successful treatment with anakinra.
    Albersmeyer MP; Hilge RG; Schulze-Koops H; Sitter T
    Rheumatology (Oxford); 2012 Sep; 51(9):1730-2. PubMed ID: 22513144
    [No Abstract]   [Full Text] [Related]  

  • 37. Whipple disease mimicking adult-onset Still's disease and treated by anakinra: diagnosis using PCR.
    Zaidan M; Berçot B; Petit A; Bardin T; Richette P
    Scand J Rheumatol; 2012 Aug; 41(4):321-3. PubMed ID: 22639877
    [No Abstract]   [Full Text] [Related]  

  • 38. Anakinra for a refractory case of intermittent hydrarthrosis with a TRAPS-related gene mutation.
    Andrés M; Pascual E
    Ann Rheum Dis; 2013 Jan; 72(1):155. PubMed ID: 22887853
    [No Abstract]   [Full Text] [Related]  

  • 39. Anakinra for the treatment of acute severe gout in critically ill patients.
    Thueringer JT; Doll NK; Gertner E
    Semin Arthritis Rheum; 2015 Aug; 45(1):81-5. PubMed ID: 25795473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of anakinra in a case of refractory Still disease.
    Debiais S; Maillot F; Luca L; Buret J; Fautrel B; Renard JP
    J Clin Rheumatol; 2008 Dec; 14(6):357-8. PubMed ID: 19033875
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.